To date, four of the eight cases of infection by Staphylococcus aureus with reduced susceptibility to vancomycin (vancomycin-intermediate S. aureus [VISA] or glycopeptideintermediate S. aureus [GISA]) have been reported in the United States (1-3). We report a fifth case of VISA infection in the United States, and the first to occur during home health-care therapy. While all previous VISA strains have been oxacillin resistant, one of the two VISA strains identified in this investigation was oxacillin susceptible.
Analytical, Diagnostic and Therapeutic Techniques and Equipment | Bacteriology | Diseases | Public Health
Use Find in Your Library, contact the author, or interlibrary loan to garner a copy of the item. Publisher policy does not allow archiving the final published version. If a post-print (author's peer-reviewed manuscript) is allowed and available, or publisher policy changes, the item will be deposited.
Hageman, J. C.,
Pegues, D. A.,
Bell, R. L.,
Ward, K. W.,
Cohen, M. D.,
Hindler, J. A.,
Tenover, F. C.,
McAllister, S. K.,
Kellum, M. E.,
Fridkin, S. K.
Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient.
Emerging Infectious Diseases, 7(6),